Abiomed Inc.
US ˙ NASDAQ ˙ US0036541003
BU SEMBOL ARTIK AKTİF DEĞİL

SecurityABMD / Abiomed Inc.
InstitutionAperio Group, LLC
Latest Disclosed Ownership24,137 shares
Latest Disclosed Value $ 7,825,000
Aperio Group, LLC reports 4.06% decrease in ownership of ABMD / Abiomed Inc.

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 24,137 shares of Abiomed Inc. (US:ABMD) valued at $7,825,215 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 25,158 shares of Abiomed Inc.. This represents a change in shares of -4.06% during the quarter. The current value of the position is $9,196,680 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F ABIOMED COM 003654100 24,137 -1,021 -4.06 7,825 12.27 0.0232
2020-11-06 2020-09-30 13F ABIOMED COM 003654100 25,158 993 4.11 6,970 19.41 0.0235
2020-08-13 2020-06-30 13F ABIOMED COM 003654100 24,165 -3,596 -12.95 5,837 44.84 0.0216
2020-05-05 2020-03-31 13F ABIOMED COM 003654100 27,761 11,114 66.76 4,030 41.90 0.0178
2020-02-13 2019-12-31 13F ABIOMED COM 003654100 16,647 -633 -3.66 2,840 -7.61 0.0102
2019-11-06 2019-09-30 13F ABIOMED COM 003654100 17,280 -2,556 -12.89 3,074 -40.51 0.0122
2019-07-30 2019-06-30 13F ABIOMED COM 003654100 19,836 -4,217 -17.53 5,167 -24.78 0.0211
2019-05-13 2019-03-31 13F ABIOMED COM 003654100 24,053 203 0.85 6,869 -11.39 0.0296
2019-05-06 2018-12-31 13F/A-1 ABIOMED COM 003654100 23,850 -733 -2.98 7,752 -29.88 0.0391
2019-02-14 2018-12-31 13F ABIOMED COM 003654100 23,813 -770 7,740
2019-05-06 2018-09-30 13F/A-1 ABIOMED COM 003654100 24,583 3,016 13.98 11,056 25.32 0.0488
2018-10-17 2018-09-30 13F ABIOMED INC COM COMMON 003654100 24,583 3,016 11,056
2019-05-06 2018-06-30 13F/A-1 ABIOMED COM 003654100 21,567 1,566 7.83 8,822 51.58 0.0422
2018-07-30 2018-06-30 13F ABIOMED INC COM COMMON 003654100 21,567 1,566 8,822
2019-05-01 2018-03-31 13F/A-1 ABIOMED COM 003654100 20,001 2,295 12.96 5,820 75.41 0.0290
2018-05-08 2018-03-31 13F ABIOMED INC COM COMMON 003654100 20,001 2,295 5,820
2019-05-01 2017-12-31 13F/A-1 ABIOMED COM 003654100 17,706 3,977 28.97 3,318 43.33 0.0171
2018-02-02 2017-12-31 13F ABIOMED INC COM COMMON 003654100 17,706 3,977 3,318
2019-05-01 2017-09-30 13F/A-1 ABIOMED COM 003654100 13,729 531 4.02 2,315 22.36 0.0131
2017-10-25 2017-09-30 13F ABIOMED INC COM COMMON 003654100 13,729 531 2,315
2019-04-22 2017-06-30 13F/A-1 ABIOMED COM 003654100 13,198 853 6.91 1,892 22.46 0.0116
2017-07-18 2017-06-30 13F ABIOMED INC COM COMMON 003654100 13,198 853 1,891
2019-04-22 2017-03-31 13F/A-1 ABIOMED COM 003654100 12,345 -1,330 -9.73 1,545 0.26 0.0106
2017-05-05 2017-03-31 13F ABIOMED INC COM COMMON 003654100 12,345 -1,330 1,546
2019-04-22 2016-12-31 13F/A-1 ABIOMED COM 003654100 13,675 -2,402 -14.94 1,541 -25.45 0.0118
2017-02-14 2016-12-31 13F ABIOMED INC COM COMMON 003654100 13,675 -2,402 1,541
2019-04-12 2016-09-30 13F/A-1 ABIOMED COM 003654100 16,077 4,048 33.65 2,067 57.19 0.0150
2016-11-01 2016-09-30 13F ABIOMED INC COM COMMON 003654100 16,077 4,048 2,067
2019-04-12 2016-06-30 13F/A-1 ABIOMED COM 003654100 12,029 4,784 66.03 1,315 91.41 0.0103
2016-08-12 2016-06-30 13F ABIOMED INC COM COMMON 003654100 12,029 4,784 1,315
2019-04-12 2016-03-31 13F/A-1 ABIOMED COM 003654100 7,245 1,001 16.03 687 21.81 0.0059
2016-04-28 2016-03-31 13F ABIOMED INC COM COMMON 003654100 7,245 1,001 687
2016-01-21 2015-12-31 13F ABIOMED INC COM COMMON 003654100 6,244 79 1.28 564 -1.40 0.0052
2015-10-19 2015-09-30 13F ABIOMED INC COM COMMON 003654100 6,165 335 5.75 572 49.35 0.0058
2015-07-29 2015-06-30 13F ABIOMED INC COM COMMON 003654100 5,830 509 9.57 383 0.52 0.0040
2015-04-29 2015-03-31 13F ABIOMED INC COM COMMON 003654100 5,321 5,321 381 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.